DK1448207T3 - Doseringsplan og farmaceutisk sammensætning af nödprævention - Google Patents

Doseringsplan og farmaceutisk sammensætning af nödprævention

Info

Publication number: DK1448207T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; dosage schedule; emergency contraception; contraception; emergency
Prior art date: 2001-11-27

Application number

DK02783334T

Other languages

Danish (da)

English (en)

Inventor

Look Paul F A Van

Illesne Balogh

Katalin Komandi

Laszlo Nemes

Zsolt Szabo

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2002-11-26

Publication date

2005-06-27

2002-11-26 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

2005-06-27 Application granted granted Critical

2005-06-27 Publication of DK1448207T3 publication Critical patent/DK1448207T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

DK02783334T 2001-11-27 2002-11-26 Doseringsplan og farmaceutisk sammensætning af nödprævention DK1448207T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HU0105173A HU227198B1 (en)	2001-11-27	2001-11-27	Pharmaceutical composition for emergency contraception containing levonorgestrel
EP02783334A EP1448207B1 (fr)	2001-11-27	2002-11-26	Posologie et composition pharmaceutique pour contraception d'urgence
PCT/HU2002/000129 WO2003045397A1 (fr)	2001-11-27	2002-11-26	Posologie et composition pharmaceutique pour contraception d'urgence

Publications (1)

Publication Number	Publication Date
DK1448207T3 true DK1448207T3 (da)	2005-06-27

Family

ID=89998939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02783334T DK1448207T3 (da)	2001-11-27	2002-11-26	Doseringsplan og farmaceutisk sammensætning af nödprævention

Country Status (33)

Country	Link
US (1)	US20050288264A2 (fr)
EP (1)	EP1448207B1 (fr)
JP (1)	JP2005516904A (fr)
KR (1)	KR100908161B1 (fr)
CN (1)	CN1551774A (fr)
AP (1)	AP1849A (fr)
AT (1)	ATE293978T1 (fr)
AU (1)	AU2002347401A1 (fr)
BR (1)	BR0210595A (fr)
CA (1)	CA2450359C (fr)
DE (1)	DE60203929T2 (fr)
DK (1)	DK1448207T3 (fr)
EA (1)	EA006545B1 (fr)
EC (1)	ECSP045171A (fr)
ES (1)	ES2239727T3 (fr)
GE (1)	GEP20063882B (fr)
HR (1)	HRP20040584B1 (fr)
HU (1)	HU227198B1 (fr)
IL (1)	IL159394A0 (fr)
IS (1)	IS2691B (fr)
MA (1)	MA27076A1 (fr)
MX (1)	MXPA04005104A (fr)
NO (1)	NO333984B1 (fr)
NZ (1)	NZ530056A (fr)
OA (1)	OA12730A (fr)
PL (1)	PL206010B1 (fr)
PT (1)	PT1448207E (fr)
RS (1)	RS50768B (fr)
SI (1)	SI1448207T1 (fr)
TN (1)	TNSN04048A1 (fr)
UA (1)	UA79942C2 (fr)
WO (1)	WO2003045397A1 (fr)
ZA (1)	ZA200404114B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5649305B2 (ja) *	2006-12-20	2015-01-07	テバウィメンズヘルスインコーポレイテッド	プロゲスチンを含む口腔内崩壊性固体剤形ならびにその製造方法および使用方法
EA201070715A1 (ru) *	2007-12-20	2011-02-28	Тева Вимен'С Хелс, Инк.	Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
EP2365811A1 (fr) *	2008-12-12	2011-09-21	Laboratoire HRA Pharma	Méthode de contraception
JP5951480B2 (ja)	2009-04-14	2016-07-13	ラボラトワール・アシュエールア−ファルマＬａｂｏｒａｔｏｉｒｅＨｒａ−Ｐｈａｒｍａ	オンデマンド避妊方法
ES2625950T3 (es) *	2009-06-23	2017-07-21	Bayer Intellectual Property Gmbh	Composición farmacéutica para la anticoncepción de emergencia
CN101732324B (zh) *	2009-12-31	2011-12-07	广州朗圣药业有限公司	一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
PL2714712T3 (pl)	2011-06-01	2017-05-31	Estetra S.P.R.L.	Metoda wytwarzania półproduktów estetrolu
MX341561B (es)	2011-06-01	2016-08-25	Estetra Sprl	Proceso para la produccion de intermediarios de estetrol.
EP2383279A1 (fr)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Procédé de préparation d'estetrol
HUE033590T2 (hu) *	2011-08-11	2017-12-28	Estetra Sprl	Esztetrol alkalmazása sürgõsségi fogamzásgátlóként
EP2922552A1 (fr)	2012-11-22	2015-09-30	Bayer Pharma Aktiengesellschaft	Utilisation et schémas posologiques d'application d'une composition pharmaceutique contenant du lévonorgestrel et un inhibiteur de cox pour la contraception à la demande
CA2913085A1 (fr)	2013-05-23	2014-11-27	Bernhard Lindenthal	Composition pharmaceutique et son utilisation, ainsi que schema d'emploi de cette composition pharmaceutique pour la contraception a la demande
CN103877058A (zh) *	2014-03-26	2014-06-25	邵娜	一种左炔诺孕酮片及其制备工艺
LT3310345T (lt)	2015-06-18	2021-06-25	Estetra Sprl	Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr)	2015-06-18	2021-04-30	Estetra Sprl	Comprimé orodispersible comprenant estetrol
JP6863547B2 (ja)	2015-06-18	2021-04-21	エステトラソシエテプリーヴアレスポンサビリテリミテ	エステトロール成分を含有する口腔内崩壊性投与単位
JP6866560B2 (ja)	2015-06-18	2021-04-28	エステトラソシエテプリーヴアレスポンサビリテリミテ	エステトロール成分を含有する口腔内崩壊性投与単位
CA3178291A1 (fr)	2016-08-05	2018-04-12	Estetra Srl	Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar)	2018-04-19	2019-10-19	Estetra Sprl	مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) *	2019-12-12	2020-03-27	上海信谊天平药业有限公司	一种左炔诺孕酮片的制备方法
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
WO2022026901A2 (fr) *	2020-07-30	2022-02-03	Acer Therapeutics Inc.	Antagonistes nk pour la contraception
CN119523923A (zh) *	2024-11-21	2025-02-28	华中药业股份有限公司	一种左炔诺孕酮片及其制备方法

2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
2002
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 CA CA2450359A patent/CA2450359C/fr not_active Expired - Lifetime
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/fr not_active Ceased
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko not_active Expired - Lifetime
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 EP EP02783334A patent/EP1448207B1/fr not_active Expired - Lifetime
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200404114B (en)	2005-10-26
PT1448207E (pt)	2005-08-31
HUP0105173A2 (hu)	2003-08-28
KR100908161B1 (ko)	2009-07-16
OA12730A (fr)	2006-06-28
CN1551774A (zh)	2004-12-01
MA27076A1 (fr)	2004-12-20
RS50768B (sr)	2010-08-31
AP2004003046A0 (en)	2004-06-30
AU2002347401A1 (en)	2003-06-10
EP1448207A1 (fr)	2004-08-25
JP2005516904A (ja)	2005-06-09
UA79942C2 (en)	2007-08-10
HU227198B1 (en)	2010-10-28
PL369520A1 (en)	2005-04-18
CA2450359C (fr)	2011-05-10
KR20040066088A (ko)	2004-07-23
IS2691B (is)	2010-10-15
ES2239727T3 (es)	2005-10-01
TNSN04048A1 (en)	2006-06-01
HUP0105173A3 (en)	2004-03-29
CA2450359A1 (fr)	2003-06-05
AP1849A (en)	2008-05-23
HRP20040584A2 (en)	2005-02-28
BR0210595A (pt)	2004-06-08
EA200400731A1 (ru)	2004-12-30
GEP20063882B (en)	2006-07-25
HRP20040584B1 (en)	2012-11-30
MXPA04005104A (es)	2004-08-19
SI1448207T1 (en)	2005-10-31
US20050032755A1 (en)	2005-02-10
EA006545B1 (ru)	2006-02-24
PL206010B1 (pl)	2010-06-30
EP1448207B1 (fr)	2005-04-27
IS7065A (is)	2003-12-05
NO333984B1 (no)	2013-11-04
DE60203929D1 (de)	2005-06-02
NO20041607L (no)	2004-04-20
ATE293978T1 (de)	2005-05-15
IL159394A0 (en)	2004-06-01
RS4204A (sr)	2007-02-05
HUP0105173D0 (en)	2002-02-28
ECSP045171A (es)	2004-08-27
US20050288264A2 (en)	2005-12-29
DE60203929T2 (de)	2006-01-19
WO2003045397A1 (fr)	2003-06-05
NZ530056A (en)	2005-02-25

Publication	Publication Date	Title
DK1448207T3 (da)	2005-06-27	Doseringsplan og farmaceutisk sammensætning af nödprævention
DK1562556T3 (da)	2013-03-25	Farmaceutiske sammensætninger og doseringsformer af thalidomid
ATE296619T1 (de)	2005-06-15	Feste orale dosierungsform von simethicon
BRPI0209720A2 (pt)	2017-06-13	dosagem e embalagem de medicação com liberação controlada
DE60121992D1 (de)	2006-09-14	Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
DK1478339T3 (da)	2008-08-25	Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
DK1158992T3 (da)	2003-12-29	Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
PT1207867E (pt)	2006-07-31	Formas de administracao farmaceuticas orais retardadas contendo tramadol
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
HUP0401656A3 (en)	2012-05-02	Mch antagonists for the treatment of obesity and pharmaceutical compositions containing them
DK1537096T3 (da)	2009-02-02	Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
NO20033123L (no)	2003-09-03	Terapeutisk hinne dannende sammensetning og behandlingsplan derav
FI20022128A7 (fi)	2003-06-06	Farmaseuttinen koostumus
GB0108470D0 (en)	2001-05-23	Pharmaceutical compositions and their use
DK2017269T3 (da)	2012-03-05	Krystallinsk form II af ritonavirindeholdende farmaceutisk sammensætning og fremstilling heraf
PL361518A1 (pl)	2004-02-09	Zastosowanie substancji oraz kompozycja farmaceutyczna
DE60329614D1 (de)	2009-11-19	Polymerzusammensetzung sowie diese enthaltende darreichungsformen
DE60232445D1 (de)	2009-07-09	Cetirizin und pseudoephedrin enthaltende tablette
EE200300468A (et)	2004-02-16	Pravastatiini stabiilne farmatseutiline kompositsioon
NO20034172D0 (no)	2003-09-19	Bisykliske guanidinderivater og terapeutiske anvendelser derav
DK1385513T3 (da)	2007-01-15	Farmaceutiske kombinationer af pyridoindollonderivater og anticancermidler
DK1406591T3 (da)	2007-06-25	Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron
EP1413314A4 (fr)	2004-12-22	Composition medicinale
PT102642A (pt)	2002-07-31	Composicao farmaceutica de dosagem unica diaria contendo brivudine
FR2829380B1 (fr)	2004-09-10	Orthese de cicatrisation